TXG
10X Genomics Inc
76.10$
-5.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +7.3% | +15.3% | +38.1% | +6.0% | +4.2% | +9.7% | +23.0% | -4.5% | -40.3% | +67.4% | +56.3% | -5.7% | +9.5% | +8.2% | +14.6% | -20.2% | +0.1% | +14.4% | +19.2% | -14.0% | +9.3% | +4.6% | +19.7% | -23.4% | +8.6% | -0.9% | +8.8% | -6.1% | +11.6% | -13.8% | +11.4% | -9.1% | +0.1% | – | |
| – | +6.8% | +15.2% | +184.3% | -6.3% | +7.5% | +3.2% | +7.1% | -8.9% | -33.5% | +43.4% | +31.1% | -9.7% | -71.2% | +398.8% | +12.6% | -7.7% | +8.7% | +9.6% | +21.2% | -2.5% | +31.5% | +23.1% | +17.3% | -29.5% | +1.6% | -7.4% | +19.5% | -8.6% | -3.3% | +1.8% | +8.8% | -15.7% | -13.7% | – | |
| – | +7.4% | +15.3% | +13.7% | +11.1% | +3.0% | +12.0% | +28.4% | -3.3% | -42.2% | +74.7% | +62.6% | -4.9% | +25.0% | -9.1% | +15.0% | -23.2% | -2.4% | +15.9% | +18.6% | -17.6% | +1.2% | -4.1% | +21.2% | -19.8% | +12.2% | +2.1% | +4.3% | -5.0% | +18.6% | -19.8% | +12.7% | -6.1% | +6.0% | – | |
| – | -22.6% | -3.1% | +18.0% | +14.4% | +20.5% | +23.2% | +25.6% | -6.8% | +5.9% | +9.5% | +31.7% | +5.5% | +27.5% | +2.2% | +13.4% | +3.5% | +10.3% | -4.8% | -5.5% | +5.5% | +6.5% | +51.0% | -39.5% | +5.2% | -8.3% | +5.2% | +1.2% | -4.1% | -4.7% | -6.6% | -2.1% | +1.6% | -0.1% | – | |
| – | +1.2% | -9.4% | +37.1% | +2.6% | +21.1% | +0.1% | +14.2% | +35.2% | -11.9% | +16.1% | +4.9% | +5.2% | +20.7% | -9.6% | +5.0% | +2.3% | +19.0% | -7.5% | +2.4% | +10.8% | +9.9% | -9.9% | +0.5% | +3.6% | -3.2% | -1.6% | +10.1% | -0.2% | -17.0% | +1.2% | +1.7% | -13.4% | +18.5% | – | |
| – | -8.4% | -8.0% | +32.4% | +4.7% | +20.9% | +8.3% | +21.8% | +14.8% | -5.7% | +69.7% | +310.0% | -80.3% | +22.5% | -3.8% | +12.9% | -0.8% | +14.7% | -6.2% | +1.3% | +5.5% | +8.4% | +16.8% | -10.2% | -9.7% | -5.5% | +1.3% | +8.7% | -10.0% | -34.4% | +39.6% | +0.0% | -7.1% | +7.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -207.0% | – | – | – | – | |
| – | – | – | +4.4% | -0.6% | +1.6% | +1.9% | +40.1% | -33.3% | -53.8% | +29.7% | -20.2% | -30.3% | -5.4% | +4.8% | -0.9% | -41.0% | -14.8% | +4.6% | +9.6% | -84.8% | -73.7% | -80.0% | +700.0% | -87.5% | +0.0% | +100.0% | +300.0% | -100.0% | – | +0.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -176.2% | – | – | – | – | |
| – | +10.3% | +0.0% | +162.5% | -19.0% | +100.0% | -88.2% | +1,250.0% | +175.9% | +41.6% | +38.6% | +1,088.0% | -93.7% | +151.5% | -52.2% | +369.6% | -70.7% | -12.8% | +199.7% | -57.2% | +35.9% | +50.7% | -24.6% | +89.5% | -8.8% | -61.9% | +60.8% | -50.7% | +31.5% | +188.6% | -129.8% | – | -41.2% | -214.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -179.5% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -134.2% | – | -101.5% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.